Verastem (VSTM) Revenue (QoQ) (2018 - 2026)
Verastem (VSTM) Revenue (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Verastem | 166.09 Mn | -31.73 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.48% |
| Dec 31, 2025 | 55.98% |
| Sep 30, 2025 | 426.06% |
| Mar 31, 2022 | 376.33% |
| Dec 31, 2021 | 27,150.00% |
| Sep 30, 2021 | -99.60% |
| Jun 30, 2021 | -50.30% |
| Mar 31, 2021 | 98.81% |
| Dec 31, 2020 | -99.36% |
| Sep 30, 2020 | 1,726.03% |
| Jun 30, 2020 | -14.81% |
| Mar 31, 2020 | 39.78% |
| Dec 31, 2019 | -59.95% |
| Sep 30, 2019 | 188.01% |
| Jun 30, 2019 | 87.67% |
| Mar 31, 2019 | 38.10% |
| Dec 31, 2018 | -92.20% |
| Sep 30, 2018 | 55.08% |